These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22011711)

  • 1. DNA hypomethylation at the ZNF206-exon 5 CpG island associated with neuronal differentiation in mice and development of neuroblastoma in humans.
    Kawashima H; Sugito K; Yoshizawa S; Uekusa S; Furuya T; Ikeda T; Koshinaga T; Shinojima Y; Hasegawa R; Mishra R; Igarashi J; Kimura M; Wang X; Fujiwara K; Gosh S; Nagase H
    Int J Oncol; 2012 Jan; 40(1):31-9. PubMed ID: 22011711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon.
    Uekusa S; Kawashima H; Sugito K; Yoshizawa S; Shinojima Y; Igarashi J; Ghosh S; Wang X; Fujiwara K; Ikeda T; Koshinaga T; Soma M; Nagase H
    Int J Oncol; 2014 May; 44(5):1669-77. PubMed ID: 24626568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development.
    Liang P; Song F; Ghosh S; Morien E; Qin M; Mahmood S; Fujiwara K; Igarashi J; Nagase H; Held WA
    BMC Genomics; 2011 May; 12(1):231. PubMed ID: 21569359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions.
    Sugito K; Kawashima H; Uekusa S; Yoshizawa S; Hoshi R; Furuya T; Kaneda H; Hosoda T; Masuko T; Ohashi K; Ikeda T; Koshinaga T; Fujiwara K; Igarashi J; Ghosh S; Held WA; Nagase H
    Pediatr Blood Cancer; 2013 Mar; 60(3):383-9. PubMed ID: 22911660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zfp206 is a transcription factor that controls pluripotency of embryonic stem cells.
    Wang ZX; Kueh JL; Teh CH; Rossbach M; Lim L; Li P; Wong KY; Lufkin T; Robson P; Stanton LW
    Stem Cells; 2007 Sep; 25(9):2173-82. PubMed ID: 17628018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.
    Fujiwara K; Ghosh S; Liang P; Morien E; Soma M; Nagase H
    Mol Carcinog; 2015 Mar; 54(3):178-88. PubMed ID: 24115114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation profile dynamics of tissue-dependent and differentially methylated regions during mouse brain development.
    Hirabayashi K; Shiota K; Yagi S
    BMC Genomics; 2013 Feb; 14():82. PubMed ID: 23387509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse.
    Suzuki M; Sato S; Arai Y; Shinohara T; Tanaka S; Greally JM; Hattori N; Shiota K
    Genes Cells; 2007 Dec; 12(12):1305-14. PubMed ID: 18076568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel member of the snail/Gfi-1 repressor family, mlt 1, which is methylated and silenced in liver tumors of SV40 T antigen transgenic mice.
    Tateno M; Fukunishi Y; Komatsu S; Okazaki Y; Kawai J; Shibata K; Itoh M; Muramatsu M; Held WA; Hayashizaki Y
    Cancer Res; 2001 Feb; 61(3):1144-53. PubMed ID: 11221845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of frequent differentially methylated region in sporadic bladder cancers.
    Hasegawa R; Fujiwara K; Obinata D; Kawashima H; Shinojima Y; Igarashi J; Wang X; Ghosh S; Nagase H; Takahashi S
    Urol Int; 2015; 94(4):479-84. PubMed ID: 25227574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.
    Carén H; Ejeskär K; Fransson S; Hesson L; Latif F; Sjöberg RM; Krona C; Martinsson T
    Mol Cancer; 2005 Mar; 4(1):10. PubMed ID: 15740626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
    Alaminos M; Davalos V; Cheung NK; Gerald WL; Esteller M
    J Natl Cancer Inst; 2004 Aug; 96(16):1208-19. PubMed ID: 15316056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable DNMT3L overexpression in SH-SY5Y neurons recreates a facet of the genome-wide Down syndrome DNA methylation signature.
    Laufer BI; Gomez JA; Jianu JM; LaSalle JM
    Epigenetics Chromatin; 2021 Mar; 14(1):13. PubMed ID: 33750431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylation analysis in precursor B-cells.
    Almamun M; Levinson BT; Gater ST; Schnabel RD; Arthur GL; Davis JW; Taylor KH
    Epigenetics; 2014 Dec; 9(12):1588-95. PubMed ID: 25484143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
    Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
    Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.